In several preclinical studies of AML established in murine models, PD-1/PD-L1 signaling was implicated in leukemia development, e.g., inhibition of host antitumor immune responses, exhaustion of CD8+ T cells and promotion of Treg-mediated effector T cell suppression [52–54]. This evidence concerns the gene CD274 and acute myeloid leukemia.